doi: 10.1152/ajpcell.00093.2016 79 ZinmanB.NauckM
5 These broad potential indications, coupled with payer concerns about affordability, access and long-term cost-effectiveness, make it clear that GLP-1 obesity treatments are more than a passing trend and they demand robust evidence and longer term real-world monitoring
Ponneri Babuharisankar A, Kuo C-L, Chou H-Y, Tangeda V, Fan C-C, Chen C-H, et al
Chyra-JachDKaletkaZDobrakowskiMMacho-GreckaAKasperczykSBellantiFet al
During this process, track more than just weight
BPC-157: Tissue Repair BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide of 15 amino acids, derived from a protein naturally found in human gastric juice